FDA Inspection 997069 — Huvepharma Inc.

Huvepharma Inc. — FEI 1940172

The FDA completed an inspection of Huvepharma Inc. on October 26, 2016 in Saint Louis, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 26, 2016
Fiscal Year
2017
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Saint Louis, MO (United States)